3 September 2025

Access to Tirzepatide (Mounjaro®) 

‘Tirzepatide’, commonly known as Mounjaro®, is a new treatment approved by the NHS to help manage obesity and improve related health conditions. It is a weekly injection that mimics hormones in your gut to help you feel full for longer and manage blood sugar levels It is currently available to people who have:

A Body Mass Index (BMI) of 40 or more.

And have, at least 4 of the following health conditions:

  - type 2 diabetes
  - high blood pressure
  - heart disease
  - obstructive sleep apnoea
  - abnormal blood fats

If you are from a South Asian, Chinese, Middle Eastern, Black African or African-Caribbean background, the BMI is 37.5 instead of 40.

West Yorkshire Integrated Care Board responsible for commissioning services in Kirklees, have not yet rolled this out to GP practices in our area.

Therefore we cannot prescribe Mounjaro® from our practice right now, or refer to a service in Kirklees that can prescribe. 

We understand patients who meet the NHS criteria are keen to understand their options.

We know who is eligible for this treatment - this is only a small number of patients.

When this treatment is available in Kirklees we will be contacting eligible patients to discuss further. You do not need to contact us.  

Further information about Tirzepatide (Mounjaro®) is available on West Yorkshire Health and Care Partnership website.

If you're living with obesity or weight-related health issues, we understand that the journey can be emotional, frustrating, and difficult - especially when services feel out of reach. If you do not meet the current criteria and want to lose weight the Kirklees Wellness Service may be able to help you. This is for people who have a BMI of 27.5 or more.

Please visit Kirklees Council website for further information about their offer. www.kirkleeswellnessservice.co.uk The NHS website also has advice on making changes to your lifestyle to help you lose weight.  Tips to help you lose weight - NHS